SAV1 and neoplasm: Among the 94 tumor samples studied, the relative level of SAV1 mRNA (tumor tissue vs. matched non-cancerous mucosa) was reduced in eighty-eight (93.6%) tumors, while it was elevated in six (6.4%) cases (Table 1, Figure 1A).